Abstract
Lithium is the gold standard treatment for bipolar disorder. Studies have shown an association between lithium and hyperparathyroidism. However, there is limited data regarding the management of lithium-induced hyperparathyroidism. We present a clinical conundrum which physicians frequently encounter—an excellent lithium responder refractory to other treatments who developed lithium-induced hyperparathyroidism. Medical treatment with cinacalcet was successful in management of hyperparathyroidism without discontinuing lithium maintenance therapy.
Keywords
bipolar disorder, cinacalcet, hypercalcemia, hyperparathyroidism, lithium
Access This Article
This is an open access article available at no cost.
How to Cite
Vishwanath Pattan, Balwinder Singh, Sahar S Abdelmoneim, Chaitra Gopinath, Vishnu Sundaresh. Lithium-Induced Hyperparathyroidism: An Ill-defined Territory.
Psychopharmacology Bulletin.
2021/06/01; 51(3):65-71.
https://doi.org/10.64719/pb.4410
